Tuoxin Pharmaceutical Group Co.,Ltd. Stock: price and insider trades · China
拓新药业
1 insider bought €1,482 of shares over the last 90 days, the latest by 马冠军, filed 03 Sept 2026.
Tuoxin Pharmaceutical Group Co.,Ltd.: what insiders have been doing
This page follows insider dealings at Tuoxin Pharmaceutical Group Co.,Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. From 6 November 2025 to 6 November 2026, the disclosure feed for Tuoxin Pharmaceutical Group Co.,Ltd. logged 1 filing by 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €1,482, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 senior executive. Biggest ticket of the year: €1,482, bought by 马冠军 and made public on 3 September 2026.
With 1 filing in twelve months, the company is quieter than the median of 2 filings across the 522 companies we follow on the same exchange. Since 2022, the database holds 1 purchase and 10 sales by insiders of the company.
The last purchase on record was published on 3 September 2026, which is 66 days ago.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -9.2%Entry CN¥22.84 · Close 04 Nov 2026 CN¥20.74
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 500 shares@ CN¥178.6194100.0% of flowA股XSHESZSE:273000001449860860Canonical exit: 2 Dec 2026 (T+90)
- 50,000 shares25.9% of flowA股XSHESZSE:173000006306768450
- 8,600 shares6.3% of flowA股XSHESZSE:173000006136669900
- 25,000 shares9.7% of flowA股XSHESZSE:173000006130764580
- 51,300 shares36.3% of flowA股XSHESZSE:173000006130764600
- 130,000 shares63.6% of flowA股XSHESZSE:173000006118428130
- 91,000 shares57.4% of flowA股XSHESZSE:173000006112877600
- 76,500 shares36.4% of flowA股XSHESZSE:173000006108811200
- 99,500 shares34.6% of flowA股XSHESZSE:173000006108811170
- 150,000 shares55.7% of flowA股XSHESZSE:173000006091123900
- 121,000 shares74.1% of flowA股XSHESZSE:173000006084486340
11 of 11 declarations
About Tuoxin Pharmaceutical Group Co.,Ltd.
拓新药业 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
